From: SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
Variables | n | SKA1 expression | P value | |
---|---|---|---|---|
Positive Negative | ||||
All cases | 126 | 65 | 61 | Â |
Gender | 0.317 | |||
 Female | 13 | 5 | 8 |  |
 Male | 113 | 60 | 53 |  |
Age (year) | 0.457 | |||
  < 53 | 60 | 33 | 27 |  |
  ≥ 53 | 66 | 32 | 34 |  |
Tumor size (cm) | 0.002 | |||
  < 5 | 63 | 24 | 39 |  |
  ≥ 5 | 63 | 41 | 22 |  |
Differentiation | 0.155 | |||
 Well to moderate | 34 | 14 | 20 |  |
 Poor | 92 | 51 | 41 |  |
HBsAg | 0.272 | |||
 Positive | 114 | 57 | 57 |  |
 Negative | 12 | 8 | 4 |  |
Serum AFP (μg/L) | 0.035 | |||
  ≥ 200 | 74 | 44 | 30 |  |
  < 200 | 52 | 21 | 31 |  |
TNM stage | 0.009 | |||
 I + II | 92 | 41 | 51 |  |
 III + IV | 34 | 24 | 10 |  |